Athletigen teams up with CrossFit leader MobilityWOD

 

HALIFAX – September 17, 2018 – Athletigen Technologies, Inc. has announced the launch of its Optimum Movement and Recovery report, a DNA product that was created in partnership with Dr. Kelly Starrett and his company MobilityWOD.

 

The report uses 23andMe, AncestryDNA, or Athletigen DNA data, for more than 70 genetic markers to deliver 25 fundamental insights into injury risk, exercise recovery, and sleep hygiene. Customers who have already had their DNA sequenced can now use the Optimum Movement and Recovery report to gain additional knowledge about their bodies. Alternatively, if customers need a DNA kit to start their genetic journey, they can purchase one directly from Athletigen.

 

“It’s exciting to see people use their DNA to explore the depths of their unique human technology. Working together with Dr. Kelly and Juliet Starrett to deliver a solution that helps people make informed decisions for optimal performance and informed living has been pure joy,” says Athletigen CEO Dr. Jeremy Koenig. “It is an honour to work side by side with people who are experts in their craft and who are driven to help humans perform, feel, and live better. We want to continue to help people make decisions based on their individual bodies. This kind of interdisciplinary collaboration is essential to make this a reality for all humans.”

 

The Optimum Movement and Recovery report, while non-diagnostic, helps customers understand the impact of DNA on traits such as tendon and ligament injury risk, post-exercise soreness and inflammation, and sleep quality. Understanding our DNA foundation can be empowering, giving every person the ability to take charge of their health. Every person’s DNA is 99.5% the same. By understanding the 0.5% that makes each person unique, as well as the environmental factors that combine with DNA to influence athletic performance and recovery, people can make more informed lifestyle decisions daily.

 

MobilityWOD was founded in 2005 by Dr. Kelly Starrett and Juliet Starrett with the goal of becoming the ultimate guide to eliminating pain, preventing injury and maximizing athletic performance. MobilityWOD has grown into a leader in the CrossFit industry and has worked with high-profile clients such as the New Zealand All Blacks, UFC fighter Georges St. Pierre, actor Jason Statham, and author Tim Ferriss.

 

“Genetics and understanding the implication of modern genetics on my person is here to stay. It’s going to be part of the conversation,” said MobilityWOD founder Kelly Starrett. “The problem is that trying to sort through and make sense of this incredible technology is difficult, at best. So we have partnered with our friends at Athletigen to take your DNA data and translate it into actionable steps and real behaviors that can improve your life.”

 

Athletigen is funded by private equity investors, the Government of Canada through repayable loans from the Atlantic Canada Opportunities Agency, and the province of Nova Scotia through Nova Scotia Business Inc.

 

—- 30 —-
Click here for a sample version of the Optimum Movement and Recovery DNA report.

 

Media Contact

Brandon DuBreuil

brandon.dubreuil@athletigen.com

 

About Athletigen

Athletigen is a company founded on the same performance principles that are used to help the most elite athletes in the world achieve greatness. We are driven to empower all people to understand their DNA and reach their full potential. Our mission is to help people connect their DNA data to products and services that are specific to their personal needs and are aligned with a healthful life. We achieve this through adhering to the highest scientific standards, a commitment to education, and strategic alignment with partners who embrace our passion for performance. We believe that everyone is Made for More™.

 

About Athletigen’s Optimum Movement and Recovery Report

The new Optimum Movement and Recovery DNA report from Athletigen and MobilityWOD unlocks the power of raw DNA data files provided to every 23andMe and AncestryDNA customer with over 25 insights into injury risk, exercise recovery, and sleep hygiene. These traits include:

  • Tendon and ligament injury risk
  • Hamstring injury risk
  • Shoulder dislocation
  • Fracture risk and bone mineral density
  • Age-related strength loss
  • Post-exercise soreness and inflammation
  • Post-exercise recovery time
  • Soft tissue recovery
  • Sleep quality

 

About Dr. Jeremy Koenig

Dr. Jeremy Koenig, Athletigen CEO and Founder, has a background in commercializing genetic information into practical applications. Dr. Koenig was a varsity track-and-field athlete during the completion of his Ph.D. in Biochemistry and Molecular Biology at Dalhousie University in Halifax, Nova Scotia, Canada. Following graduate school, Dr. Koenig pursued postdoctoral training in human microbiome and genetics research at Cornell University. He was a Professor of Nutrigenomics, before moving to the biomedical industry to work on developing and commercializing a genetics-based fertility test. He founded Athletigen in 2014 to accelerate scientific discovery through the delivery and application of DNA to every human.

 

Athletigen Technologies Inc.,
211 Horseshoe Lake Drive,
Halifax,
Nova Scotia

2015 © Copyright - Bionova